文献速递特殊人群用药

药师管理妊娠期缺铁性贫血服务的效果评价

Evaluation of a pharmacist-managed anemia service in pregnant patients.
PubMed 文献 · Am J Health Syst Pharm · 2024-01-01

一项回顾性多中心研究比较药师管理的妊娠期缺铁性贫血患者(n=100)与标准照护组(n=100),发现药师管理组分娩时血红蛋白>11.0 g/dL的比例更高(87% vs 71%,P<0.01),平均血红蛋白更高(12.1 g/dL vs 11.6 g/dL,P<0.1),且静脉铁使用比例更低(8% vs 21%,P<0.01)。

要点

  • 药师管理组分娩时血红蛋白达标率87%,显著高于标准照护组的71%。
  • 药师管理组静脉铁使用比例8%,显著低于标准照护组的21%。
  • 两组输血比例无差异(4% vs 3%,P=0.56)。

核心结论

  • 药师参与妊娠期缺铁性贫血管理可显著改善分娩时血红蛋白水平。

研究设计与样本

  • 回顾性、仅数据、多中心研究,比较药师管理组(n=100)与标准照护组(n=100)的妊娠期缺铁性贫血患者,患者年龄≥16岁。

主要发现

  • 分娩时血红蛋白>11.0 g/dL的比例药师管理组为87%,标准照护组为71%(P<0.01)。
  • 分娩时平均血红蛋白药师管理组为12.1 g/dL,标准照护组为11.6 g/dL(P<0.1)。
  • 接受输血的比例两组分别为4%和3%(P=0.56)。
  • 接受静脉铁的比例药师管理组为8%,标准照护组为21%(P<0.01)。
  • 药师管理组中81%的患者接受口服硫酸亚铁。

临床怎么用

  • 药师可参与妊娠期缺铁性贫血的管理,以提高分娩时血红蛋白达标率并减少静脉铁使用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Studies have shown the positive impact pharmacist-managed services have on patient care. However, little information is available on services for pregnant patients. This study contributes to the current literature by providing data on the impact of a pharmacist-managed service on outcomes in pregnant patients with iron-deficiency anemia. METHODS: This was a retrospective, data-only, multicenter study comparing pregnant patients with iron-deficiency anemia managed by a pharmacist (n = 100) to those who received standard care (n = 100). During the study period, patients were 16 years of age or older and pregnant with concurrent iron-deficiency anemia. The percentage of patients with a hemoglobin level above goal (>11.0 g/dL) at delivery, the mean hemoglobin level at delivery, and the type of iron supplementation were compared between the groups. RESULTS: The percentage of patients with a hemoglobin level of greater than 11.0 g/dL at delivery was 87% for the pharmacist-managed group compared to 71% for the group receiving standard care (P < 0.01). The mean hemoglobin level at delivery was significantly higher in the pharmacist-managed group than in the group receiving standard care, at 12.1 g/dL vs 11.6 g/dL, respectively (P < 0.1). There was no difference between the groups in the percentage of patients receiving blood transfusions (4% vs 3%; P = 0.56). The percentage of patients who received intravenous iron was significantly lower in the pharmacist-managed group than in the group receiving standard care (8% vs 21%; P < 0.01). Most patients in the pharmacist-managed group received oral ferrous sulfate (81%). CONCLUSION: This study showed that including pharmacists in the management of pregnant patients with iron-deficiency anemia significantly improved patient hemoglobin levels at delivery.

来源:Am J Health Syst Pharm,查看原文。版权归原作者所有。

引用

  1. Weaver D, Cheung S, deLaunay A, et al. Evaluation of a pharmacist-managed anemia service in pregnant patients. Am J Health Syst Pharm. 2024. PMID: 37996073. doi:10.1093/ajhp/zxad293

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。